Key result
Endometriosis in young women is linked to ~4.6-point lower flow-mediated dilation versus controls.
Cross-Sectional (n=68)
Mean Difference: -4.62 (95% CI -6.52–-2.73)
p-value: p=< 0.001
BACKGROUND: Atherosclerosis is a chronic and degenerative disease developing typically in the elderly; nonetheless, a condition of accelerated atherosclerosis can be observed precociously in the presence of some diseases. Endometriosis, a chronic benign gynecological disorder, shows some characteristics, such as oxidative stress, systemic inflammation and a pro-atherogenic lipid profile, which could increase the risk of developing accelerated atherosclerosis. The aim of our study was to evaluate markers of subclinical atherosclerosis in young European women with endometriosis. METHODS: This cross-sectional study included 37 women with endometriosis and 31 control subjects. The presence of subclinical atherosclerosis was investigated by ultrasound evaluation of common carotid intima-media thickness (ccIMT) and flow-mediated dilation (FMD); in addition, serum levels of lipids, inflammatory and coagulation parameters, as well as markers of endothelial inflammation and activation, were determined. RESULTS: Women with endometriosis showed significantly lower values of FMD compared with controls [mean difference: -4.62, 95% confidence interval (CI): -6.52, -2.73; P < 0.001], whereas no significant differences in ccIMT values were found between the two groups. As regards markers of endothelial inflammation and activation, women with endometriosis had significantly higher values of inter-cellular adhesion molecule 1 (P < 0.001), vascular cell adhesion molecule 1 (P < 0.001), E-selectin (P < 0.001), von Willebrand factor (P = 0.004) and ristocetin cofactor (P = 0.001) compared with controls. CONCLUSIONS: Our study suggests that women with endometriosis have more subclinical atherosclerosis, resulting in a higher risk of developing cardiovascular disorders. Moreover, our findings demonstrate that endothelial dysfunction can occur in the absence of structural atherosclerotic changes; its evaluation might be helpful in young women with endometriosis.
No takes yet. Share an insight, caveat, or question.
Santoro et al. (2012) conducted a cross-sectional in Endometriosis (n=68). Endometriosis vs. Control subjects without endometriosis was evaluated on Flow-mediated dilation (FMD) (MD -4.62, 95% CI -6.52, -2.73, p=< 0.001). Endometriosis in young women was associated with significantly lower flow-mediated dilation compared to controls (mean difference -4.62; 95% CI -6.52 to -2.73; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: